
Natacha Lobos
- Special Engineer; Bsc, Msc
- +47 22 78 23 18
Barnekreftforeningen (PERCAP)
Education:
2021-2022 – MSc in Molecular Biology and Biochemistry – UiO, Oslo | Main studies: Molecular Biology, Cancer Biology and Immunology.
2014-2019 – BSc in Biochemistry and Biomedicine Sciences – University of Valencia, Spain | Main studies: Biochemistry, Molecular Biology and Genetics.
Research interests/projects:
- Development of novel cellular therapies (CARs, engineered TCRs)
- Cancer Immunotherapy
Work Experience:
2023-Present – Special Engineer, Dept. of Cellular Therapy, OUS Radiumhospitalet, Oslo, Norway
2022-2023 – Researcher, Dept. of Biosciences, UiO, Oslo, Norway
2022 – Visiting Researcher, Dept. of Immunology, Infectiology and Hematology, Institute Necker Enfants Malades, Paris, France
2020-2022 – Principal Engineer, Dept. of Biosciences, UiO, Oslo, Norway
2017-2018 – Internship, Dept. of Biosciences, UiO, Oslo, Norway
2017 – Internship, Principe Felipe Research Center Foundation, Valencia, Spain
Grant and awards:
2020-2023 – Forskingsrådet Research Fellowship
2022 – The Count Hjelmstjerne-Rosencroneske Foundation Travel Grant
2017-2018 – Erasmus+ Studying abroad Grant
Publications:
Lobos Patorniti N, Zulkefli KL, McAdam ME, Vargas P, Bakke O and Progida C (2023) Rai14 is a novel interactor of Invariant chain that regulates macropinocytosis. Front. Immunol. 14:1182180. doi: 10.3389/fimmu.2023.1182180